Global Veterinary-Animal Vaccines Market, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Other Animal Vaccines), Disease (Porcine, Poultry, Livestock, Companion Animals, Aquaculture), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), Route of Administration (Oral, Parenteral, Topical), End-Use (Hospitals, Clinics) – Industry Trends and Forecast to 2030.
Veterinary-Animal Vaccines Market Analysis and Size
The growing cattle disease outbreaks and the increasing livestock population are major factors for the huge acceptance of ruminants, particularly cattle vaccines. The incidence of most livestock illnesses is partly because of veterinarians' lack of experience in diagnosing and reporting the condition. Concerning vaccine production is increasing rapidly.
Data Bridge Market Research analyses that the veterinary-animal vaccines market, which was USD 10.69 billion in 2022, would rise to USD 18.23 billion by 2030 and is expected to undergo a CAGR of 6.9% during the forecast period from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Veterinary-Animal Vaccines Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Other Animal Vaccines), Disease (Porcine, Poultry, Livestock, Companion Animals, Aquaculture), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), Route of Administration (Oral, Parenteral, Topical), End-Use (Hospitals, Clinics)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Bayer AG (Germany), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Merck & Co., Inc. (U.S.), Ceva (France), Cargill, Incorporated (U.S.), Boehringer Ingelheim International GmbH. (Germany), Takeda Pharmaceutical Company Limited (Japan), Zoetis (U.S.), Dechra Pharmaceuticals PLC (U.K.), Hester Biosciences Limited. (India), Elanco (U.S.), Phibro Animal Health Corporation (U.S.), Indovax (India)
|
|
Market Opportunities
|
|
Market Definition
Veterinary-animal vaccines prevent several livestock diseases from spreading, protecting animal and human health. Food, milk, meat, protein, and other commercial items such as leather and wool derive from animals. Rabies vaccinations, foot and mouth disease vaccines, and equine influenza virus vaccines are among the most widely used veterinary vaccines, which prevent the transfer of infectious pathogens by simulating naturally acquired immunity.
Global Veterinary-Animal Vaccines Market Dynamics
Drivers
- Increasing Research Activities Associated with Veterinary-animal vaccines
An increasing number of research activities have been done for the betterment of the market growth. For instance, the U.K. announced the establishment a U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, aiming to increase vaccine development for livestock and control the spread of viral diseases. The U.K. government will contribute USD 24.79 million, whereas the Bill & Melinda Gates Foundation will contribute USD 19.43 million to launch this center. Thus, the research initiatives adopted by several market players and huge government support will expand the market growth. This factor leads to the growth of the market.
- Increasing Demand for Attenuated Live Vaccines
The attenuated live vaccines have recently led to huge market growth. Live attenuation is the most traditional vaccination method used in the veterinary field. This method is also under trial for the development of added applications. Some of these options include the development of protein subunit vaccines for swine, which are given intramuscularly. These products help decrease the mortality rate and enhance the life span of disease-affected swine. Thus, this factor help in the market growth.
Opportunities
- Increasing Demand for Intranasal Administration
The intranasal segment is expected to grow greatly due to its growing popularity. Mostly, intranasal vaccines are limited to a single dose of vaccine. The growing incidence of respiratory diseases in animals and research activities by major market players to develop better vaccines are anticipated to boost the market growth. Thus, this factor boosts market growth.
- Increasing Strategic Developments Associated with Veterinary-animal vaccines
Various companies are continuously launching veterinary-animal vaccine products, creating many market growth opportunities. For instance, Ceva partnered with the French National Research Institute for Agriculture, Food, and Environment (INRAE) for R&D to prevent several infectious diseases from animal origin and improve animal health in 2021. Furthermore, Zoetis launched the Poulvac Procerta HVT-IBD vaccine to protect poultry against Infectious Bursal Disease (IBD) in 2021. Thus, this factor serves as a major factor that increases market growth.
Restraints/Challenges
- Side-Effects of Veterinary-Animal Vaccines
Several effects are associated with veterinary-animal vaccine products. Local effects such as discomfort and local swelling at the vaccination site, decreased appetite and activity, mild fever, sneezing, a snotty nose, and mild coughing. Thus, this factor impedes market growth.
This veterinary-animal vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary-animal vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Boehringer Ingelheim India launched a single-shot poultry vaccine, VAXXITEK HVT+IBD. VAXXITEK HVT+IBD is a novel recombinant vaccine that offers life-long protection for all producing chickens, including layer, broiler, and breeder chickens. It protects against two important immunosuppressive diseases such as IBD (Infectious Bursal Disease) and Marek's Disease
Global Veterinary- Animal Vaccines Market Scope
The veterinary-animal vaccines market is segmented on the basis of type, disease, technology, route of administration, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Bovine
- Small Ruminant
- Companion Animal Vaccines
- Canine
- Feline
- Aquaculture Vaccines
- Other Animal Vaccines
Disease
- Porcine
- Poultry
- Livestock
- Bovine
- Small Ruminant
- Companion Animals
- Canine
- Feline
- Aquaculture
Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Other Vaccines
Route of Administration
- Oral
- Parenteral
- Topical
End Use
- Hospitals
- Clinics
Veterinary- Animal Vaccines Market Regional Analysis/Insights
The veterinary-animal vaccines market is analyzed and market size insights and trends are provided by type, disease, technology, route of administration, and end use as referenced above.
The countries covered in the veterinary-animal vaccines market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to grow during the forecast period veterinary-animal vaccines market due to the increasing occurrences of livestock and zoonotic diseases, resulting in many animal deaths in this region. Furthermore, improvement in animal health expenditure and the wide presence of renowned pharmaceutical companies will increase this region's market's growth rate.
Asia-Pacific dominates the market in the forecast period because of the rising livestock population in this region. The increase in the livestock population and government initiatives, particularly in emerging economies, are some of the main factors anticipated to surge the market growth in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The veterinary-animal vaccines market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for veterinary-animal vaccines market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the veterinary-animal vaccines market. The data is available for historic period 2011-2021.
Competitive Landscape and Veterinary- Animal Vaccines Market Share Analysis
The veterinary-animal vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to veterinary-animal vaccines market.
Some of the major players operating in the veterinary-animal vaccines market are:
- Bayer AG (Germany)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Merck & Co., Inc. (U.S.)
- Ceva (France)
- Cargill, Incorporated (U.S.)
- Boehringer Ingelheim International GmbH. (Germany)
- Takeda Pharmaceutical Company Limited (Japan)
- Zoetis (U.S.)
- Dechra Pharmaceuticals PLC (U.K.)
- Hester Biosciences Limited. (India)
- Elanco (U.S.)
- Phibro Animal Health Corporation (U.S.)
- Indovax (India)
SKU-